News
BIO
326.16
-0.72%
-2.35
Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan's 43rd Annual Healthcare Conference
Barchart · 13h ago
Implied FELV Analyst Target Price: $35
NASDAQ · 12/30/2024 14:31
Weekly Report: what happened at BIO last week (1223-1227)?
Weekly Report · 12/30/2024 09:29
Weekly Report: what happened at BIO last week (1216-1220)?
Weekly Report · 12/23/2024 09:30
How Is Bio-Techne’s Stock Performance Compared to Other Biotechnology Stocks?
Barchart · 12/23/2024 08:27
Benjamin Graham Detailed Fundamental Analysis - BIO
NASDAQ · 12/20/2024 21:00
Is Bio-Rad Laboratories (NYSE:BIO) Using Too Much Debt?
Simply Wall St · 12/16/2024 18:06
Weekly Report: what happened at BIO last week (1209-1213)?
Weekly Report · 12/16/2024 09:31
Broad Market Gains Shape Moat Strategies For 2025
Seeking Alpha · 12/11/2024 10:20
Market Leadership Is Narrow. Your Portfolio Shouldn't Be
Seeking Alpha · 12/10/2024 07:40
Bio-Rad Laboratories Is Maintained at Outperform by RBC Capital
Dow Jones · 12/09/2024 13:59
Bio-Rad Laboratories Price Target Raised to $481.00/Share From $369.00 by RBC Capital
Dow Jones · 12/09/2024 13:59
RBC Capital Maintains Outperform on Bio-Rad Laboratories, Raises Price Target to $481
Benzinga · 12/09/2024 13:49
RBC Capital Remains a Buy on Bio-Rad Laboratories (BIO)
TipRanks · 12/09/2024 11:41
Weekly Report: what happened at BIO last week (1202-1206)?
Weekly Report · 12/09/2024 09:30
How Is Thermo Fisher Scientific’s Stock Performance Compared to Other Medical Devices Stocks?
Barchart · 12/05/2024 08:06
Weekly Report: what happened at BIO last week (1125-1129)?
Weekly Report · 12/02/2024 09:30
Pick BMY Stock Over JNJ?
NASDAQ · 11/28/2024 04:47
Why Bio-Rad Laboratories Is Overvalued: A Fundamental And DCF Analysis
Seeking Alpha · 11/25/2024 18:21
Is Bio-Rad Laboratories, Inc. (NYSE:BIO) Potentially Undervalued?
Simply Wall St · 11/25/2024 16:20
More
Webull provides a variety of real-time BIO stock news. You can receive the latest news about Bio Rad Labs Inc through multiple platforms. This information may help you make smarter investment decisions.
About BIO
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Its Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes and food testing regimes. The Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are primarily sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.